Premium
Inappropriate Implantable Cardioverter Defibrillator Discharge Following Consumption of a Dietary Weight Loss Supplement
Author(s) -
MCBRIDE BRIAN F.,
GUERTIN DANETTE,
WHITE C. MICHAEL,
KLUGER JEFFREY
Publication year - 2004
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2004.00627.x
Subject(s) - medicine , sotalol , implantable cardioverter defibrillator , tachycardia , cardiology , weight loss , anesthesia , atrial fibrillation , obesity
This report describes the clinical course of a 40‐year‐old female who experienced repetitive ICD firing after consuming Metabolife 356, a multicomponent dietary weight loss supplement. Following the initiation of Metabolife 356, the patient experienced four shocks over a 3 day period with two 30 J shocks being delivered sequentially. Interrogation of the device revealed atrial tachycardia with 1:1 AV conduction at a rate of 240 beats/min. Metabolife 356 was discontinued and the dosage of sotalol was increased to 120 mg twice daily without recurrence of ICD discharge.